The creation of this unit, called ND3, which seeks to generate research and solutions aimed at improving public health, was described as a major step forward in scientific development
Universidad de Talca opened the country’s first center dedicated to applying nanotechnology to biomedicine. The Center for Nanomedicine, Diagnostics and Drug Development (ND3) was highlighted as an important scientific advance for both the Maule Region and the country.
“Drug development is an area that has a strong impact on people. As we have new medicines generated with new technologies, precisely thanks to nanotechnology, we can more efficiently combat the diseases that affect the population,” said the university’s rector, Carlos Torres.
The director of ND3 and academic at the university’s School of Medicine, Cristian Vilos, said this “is the first national center focused on nanomedicine and connects us with the main health stakeholders.”
According to the researcher, there are various needs in this area in the country. “There are many problems associated with highly prevalent pathologies and diseases. Therefore, as researchers we feel we have a lot to do.”
He also explained that this initiative will open new possibilities to carry out frontier research, apply for funding and train people in this field.
One of the members of ND3’s scientific advisory board is Dr. Dora Altbir Drullinsky, 2019 Chilean National Prize in Exact Sciences and director of the Center for the Development of Nanoscience and Nanotechnology at Universidad de Santiago (CEDENNA), who emphasized that “the Center will contribute a great deal so that different technologies based on nanomaterials can become part of standard treatments in our country.”
The scientist stressed that this new space will play a relevant role in developing knowledge and proposing medical solutions to the problems currently affecting the population.
